Roberta Burden

Source: https://pure.qub.ac.uk/en/persons/roberta-burden/ Parent: https://www.qub.ac.uk/courses/undergraduate/pharmaceutical-biotechnology-sandwich-bsc-b213/

View Scopus Profile

Roberta Burden

Senior Lecturer, School of Pharmacy
Material and Advanced Technologies for Healthcare
Phone+44 (0)28 9097 2176
Emailr.burden@qub.ac.uk
Room 0G.008 - Pharmacy & MCI

United Kingdom

Accepting PhD Students

PhD projects

Open to PhD applications in the fields of protease biology and inhibitor development (small molecule and biological inhibitors).

2003Research output 2003: 1Research output 2004: 1Research output 2007: 2Research output 2008: 3Research output 2009: 1Research output 2010: 1Research output 2011: 2Research output 2012: 2Research output 2013: 1Research output 2015: 4Research output 2016: 4Research output 2017: 1Research output 2018: 4Research output 2019: 9Research output 2020: 4Research output 2021: 6Research output 2022: 2Research output 2023: 3Projects 2024: 1Research output 2024: 22024

Research activity per year

Personal profile

Research Statement

Dr Burden began her scientific career by achieving a BSc (Hons) 2.1 degree in Biochemistry at Queen’s University Belfast in 2002. Following this she undertook a Masters degree in Medical Sciences within the Department of Haematology at the university, where her research was focused on delineating a molecular signature in Chronic Myeloid Leukaemia. In 2003, Dr Burden transferred to the School of Pharmacy when she was awarded a DEL CAST award to commence her PhD studies in the area of protease biochemistry. This work was focused on the development of novel inhibition strategies for targeting the cysteine cathepsin family of proteases. During this time, Dr Burden developed and characterized several biologic-based inhibitors (recombinant protein and antibodies) that resulted in a number of patent applications and publications.

Upon completion of her PhD, Dr Burden embarked upon her postdoctoral career in 2007 when she was appointed as a Knowledge Transfer Partnership associate in a collaboration between the Centre for Cancer Research and Cell Biology and Fusion Antibodies Ltd. This project was focused on the further development of the therapeutics that had been developed during her PhD studies in a number of tumour models and the identification of novel therapeutic targets in lung carcinomas that could also be amenable to antibody based targeting. Within Fusion Antibodies, Dr Burden was promoted to Team Leader within the R&D department and was responsible for liaising with the company directors and investors, giving regular updates on the scientific research that was being undertaken within the company.

After her time in industry, Dr Burden returned to academic research to undertake postdoctoral positions in the Drug Discovery research group within the Centre for Cancer Research and Cell Biology and the Molecular Therapeutics Research cluster within the School of Pharmacy. Her research in the Drug Discovery group was focused on characterizing novel targets for breast cancer treatment, whilst in the School of Pharmacy she undertook a MRC-funded postdoctoral position focused on the molecular and pharmacological evaluation of Cathepsin S as a target for disease treatment.

In June 2012, Dr Burden was appointed as a Lecturer in Pharmacology in the Molecular Therapeutics research cluster within the School of Pharmacy. Her research interest is primarily centered around the cellular microenvironment (in both health and disease) and regulatory mechanisms mediated by proteases and chemokines. Currently, Dr Burden’s work is focused on ageing and inflammatory maladies such as cancer, cardiovascular disease and fibrosis.

Research Interests

Microenvironment
Inflammation
Ageing
Tumourigenesis
Fibrosis
Proteases
Therapeutics
Angiogenesis
Chemokines
Senescence

Teaching

PMY1014: Introduction to Pharmacy Practice Skills
PMY2002: Medicinal Substances: Structure and Function
PMY2104: The Pharmacological basis of Therapeutics
PMY2105: Clinical Therapeutics 1
PMY3082: Applied Pharmaceutical Analysis and Drug Design
PMY3174: Clinical Therapeutics 2

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics where Roberta Burden is active. These topic labels come from the works of this person. Together they form a unique fingerprint.